Birchview Capital’s Arvinas ARVN Stock Holding History

Birchview Capital’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,000	Closed	-$211K	–	72
2025 Q1	$211K	Buy	30,000 +15,000	+100%	+$235K	0.18%	52
2024 Q4	$288K	Hold	15,000	–	–	0.23%	49
2024 Q3	$369K	Hold	15,000	–	–	0.32%	37
2024 Q2	$399K	Hold	15,000	–	–	0.37%	35
2024 Q1	$619K	Hold	15,000	–	–	0.5%	32
2023 Q4	$617K	Hold	15,000	–	–	0.48%	32
2023 Q3	$295K	Hold	15,000	–	–	0.25%	41
2023 Q2	$372K	Hold	15,000	–	–	0.28%	39
2023 Q1	$410K	Hold	15,000	–	–	0.32%	34
2022 Q4	$513K	Hold	15,000	–	–	0.36%	34
2022 Q3	$667K	Hold	15,000	–	–	0.47%	34
2022 Q2	$631K	Hold	15,000	–	–	0.46%	32
2022 Q1	$1.01M	Hold	15,000	–	–	0.73%	25
2021 Q4	$1.23M	Hold	15,000	–	–	0.79%	24
2021 Q3	$1.23M	Hold	15,000	–	–	0.84%	25
2021 Q2	$1.16M	Hold	15,000	–	–	0.69%	26
2021 Q1	$992K	Hold	15,000	–	–	0.59%	30
2020 Q4	$1.27M	Hold	15,000	–	–	0.73%	23
2020 Q3	$354K	Hold	15,000	–	–	0.24%	39
2020 Q2	$503K	Hold	15,000	–	–	0.3%	35
2020 Q1	$604K	Sell	15,000 -15,000	-50%	-$702K	0.54%	25
2019 Q4	$1.23M	Hold	30,000	–	–	0.9%	17
2019 Q3	$647K	Hold	30,000	–	–	0.43%	23
2019 Q2	$660K	Hold	30,000	–	–	0.4%	27
2019 Q1	$443K	Hold	30,000	–	–	0.28%	33
2018 Q4	$386K	Hold	30,000	–	–	0.37%	30
2018 Q3	$506K	Buy	+30,000	New	+$494K	0.33%	33

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Birchview Capital's ARVN Position: Q2 2025 in Review

Birchview Capital sold out of Arvinas (ARVN) in Q2 2025, closing a stake of 30,000 shares — an estimated $211K sold.

Birchview Capital first reported a position in ARVN in Q3 2018 and held it in 27 quarters. The position peaked at $1.27M in Q4 2020. 215 funds tracked by Wall St. Rank hold ARVN as of Q2 2025.

Birchview Capital reported no remaining Arvinas position as of Q2 2025 after selling out during the quarter.
Birchview Capital sold 30,000 Arvinas shares in Q2 2025, an estimated $211K.
Birchview Capital first reported a position in Arvinas in Q3 2018 and held it in 27 quarters.
Birchview Capital's Arvinas position peaked at $1.27M in Q4 2020.
215 funds tracked by Wall St. Rank held Arvinas as of Q2 2025.

Based on Birchview Capital's 13F filing for Q2 2025, filed 14 Aug 2025.